Annual Report 2020
Division of International Collaborative Research
Tomohiro Matsuda, Laureline Gatellier, Hadrien Charvat, Erika Nakao, Asako Umeda, Kazuki Nakamura, Kayo Nakata (Osaka International Cancer Center), Kumiko Saika (Saku Medical Center), Sumiyo Okawa (National Center for Global Health and Medicine)
Introduction
Based on the maintenance of an international network in the field of social medicine, we are involved in setting international standards and rules and in the standardization of research methods. We aim to establish a foundation for international collaborative research by contributing to the improvement of the research level of LMICs.
The Team and What We Do
1. Research on cancer control policies and advocacy of common cancer control measures in Asian countries
We operate as the secretariat of the Asian National Cancer Center Alliance (ANCCA), with the national cancer centers of 17 member countries, and conduct research and comparative analysis of the progress of cancer care systems and cancer control measures in each country.
2. Development of cancer registries and estimation of cancer incidence in Asian countries
We are participating in the Global Initiative for Cancer Registry Development (GICR) project to standardize the rules for cancer registry and statistics. In addition, we have concluded an MOU with Vital Strategies to estimate cancer incidence in Indonesia, Cambodia, the Philippines, Vietnam, Myanmar, Laos and other countries using statistical models.
3. Estimating the rare cancer burden in Asia and linking it to clinical trials
In the framework of Rare Cancers Asia, the RARECAREnet Asia project was launched with Korea, Taiwan, Thailand, Malaysia, and India to estimate the burden of rare cancers (incidence, survival, and prevalence), including childhood cancers.
4. Clinical research using resident-based cancer statistics as a starting point
In collaboration with IARC and IKNL, we are conducting a long-term follow-up study of cancer patients starting from population-based cancer registry database.
5. Standardization of childhood cancer stages, estimation of survival rates, and development of statistical infrastructure
The Toronto Childhood Cancer Staging System, which was proposed by the Cancer Council Queensland in Australia and is recognized as an international standard, has been applied to Japanese data, and a survival analysis (BENCHISTA study) is being conducted in collaboration with Italy and the United Kingdom.
6. Development of a data sharing method without exchanging individual information
In view of the recent demand for more rigid personal data protection in the world, we are considering shifting to a method of virtual data sharing (Vantage6) without exchanging individual information.
Research activities
We operated as the secretariat of ANCCA. We surveyed the actual situation of cancer control in each country and started a project to advocate a common cancer control plan in Asia. As part of the GICR project, we promoted a project to develop cancer registration and statistics for Vietnam. In the framework of Rare Cancers Asia, we wrote a paper on survival of rare cancers. We also analyzed the incidence of rare cancers by age group and the disparity between prefectures. We obtained a Grant-in-Aid for Scientific Research, and finalized the details of the research plan with IARC and IKNL in the Netherlands. We conducted a study using the Toronto Childhood Cancer Staging System in cooperation with cancer centers in Tokyo and Osaka, and registered more than 1300 cases.
Education
We obtained a UICC fellowship and made preparations for a researcher from Sao Paulo, Brazil to visit the NCC for training.
Future Prospects
Although we have only a small number of members, we aim to pioneer model collaborative research with researchers in other countries, and by demonstrating the results, we would like to link it to research on a larger scale and to domestic and international projects.
List of papers published in 2020
Journal
1. Nozue M, Shimazu T, Charvat H, Mori N, Mutoh M, Sawada N, Iwasaki M, Yamaji T, Inoue M, Kokubo Y, Yamagishi K, Iso H, Tsugane S. Fermented soy products intake and risk of cardiovascular disease and total cancer incidence: The Japan Public Health Center-based Prospective study. Eur J Clin Nutr, 75:954-968, 2021
2. Pilleron S, Charvat H, Araghi M, Arnold M, Fidler-Benaoudia MM, Bardot A, Grønlie Guren M, Tervonen H, Little A, O'Connell DL, Gavin A, De P, Aagard Thomsen L, Møller B, Jackson C, Bucher O, Walsh PM, Vernon S, Bray F, Soerjomataram I. Age disparities in stage-specific colon cancer survival across seven countries: An International Cancer Benchmarking Partnership SURVMARK-2 population-based study. Int J Cancer, 148:1575-1585, 2021
3. Charvat H, Shimazu T, Inoue M, Iwasaki M, Sawada N, Yamaji T, Tsugane S. Estimation of the performance of a risk prediction model for gastric cancer occurrence in Japan: Evidence from a small external population. Cancer Epidemiol, 67:101766, 2020
4. Van Alsten SC, Rabkin CS, Sawada N, Shimazu T, Charvat H, Yamaji T, Inoue M, Kemp TJ, Pinto LA, Camargo MC, Tsugane S, Song M. Metabolic Syndrome, Physical Activity, and Inflammation: A Cross-Sectional Analysis of 110 Circulating Biomarkers in Japanese Adults. Cancer Epidemiol Biomarkers Prev, 29:1639-1646, 2020
5. Saito E, Goto A, Kanehara R, Ohashi K, Noda M, Matsuda T, Katanoda K. Prevalence of diabetes in Japanese patients with cancer. J Diabetes Investig, 11:1159-1162, 2020
6. Marant Micallef C, Paul A, Charvat H, Vignat J, Houot M, Pilorget C, Straif K, El Yamani M, Soerjomataram I. An innovative method to estimate lifetime prevalence of carcinogenic occupational circumstances: the example of painters and workers of the rubber manufacturing industry in France. J Expo Sci Environ Epidemiol, 2020
7. Li M, Sun Y, Yang J, de Martel C, Charvat H, Clifford GM, Vaccarella S, Wang L. Time trends and other sources of variation in Helicobacter pylori infection in mainland China: A systematic review and meta-analysis. Helicobacter, 25:e12729, 2020
8. Miranda-Filho A, Bray F, Charvat H, Rajaraman S, Soerjomataram I. The world cancer patient population (WCPP): An updated standard for international comparisons of population-based survival. Cancer Epidemiol, 69:101802, 2020
9. Budhathoki S, Iwasaki M, Yamaji T, Hamada GS, Miyajima NT, Zampieri JC, Sharma S, Pakseresht M, Kolahdooz F, Ishihara J, Takachi R, Charvat H, Marchand LL, Tsugane S. Doneness preferences, meat and meat-derived heterocyclic amines intake, and N-acetyltransferase 2 polymorphisms: association with colorectal adenoma in Japanese Brazilians. Eur J Cancer Prev, 29:7-14, 2020
10. Wei W, Zeng H, Zheng R, Zhang S, An L, Chen R, Wang S, Sun K, Matsuda T, Bray F, He J. Cancer registration in China and its role in cancer prevention and control. Lancet Oncol, 21:e342-e349, 2020
11. Usui Y, Ito H, Koyanagi Y, Shibata A, Matsuda T, Katanoda K, Maeda Y, Matsuo K. Changing trend in mortality rate of multiple myeloma after introduction of novel agents: A population-based study. Int J Cancer, 147:3102-3109, 2020
12. Saito E, Hori M, Matsuda T, Yoneoka D, Ito Y, Katanoda K. Long-term Trends in Prostate Cancer Incidence by Stage at Diagnosis in Japan Using the Multiple Imputation Approach, 1993-2014. Cancer Epidemiol Biomarkers Prev, 29:1222-1228, 2020
13. Saika K, Matsuda T. International comparison of lip, oral cavity and pharynx cancer incidence. Jpn J Clin Oncol, 50:479-480, 2020
14. Okuyama A, Matsuda T. Age-specific lung cancer incidence rate in the world. Jpn J Clin Oncol, 50:836-837, 2020
15. Niino M, Matsuda T. Age-specific corpus uteri cancer incidence rate in the world. Jpn J Clin Oncol, 50:1344-1345, 2020
16. Matsuzaki Y, Saruki N, Matsuda T. [The analysis of newspaper articles' reporting of legislation relating to Cancer Registries]. Nihon Koshu Eisei Zasshi, 67:247-260, 2020
17. Matsuda T, Won YJ, Chun-Ju Chiang R, Lim J, Saika K, Fukui K, Lee WC, Botta L, Bernasconi A, Trama A. Rare cancers are not rare in Asia as well: The rare cancer burden in East Asia. Cancer Epidemiol, 67:101702, 2020
18. Matsuda T, Saika K. Age-specific cancer incidence rate in the world. Jpn J Clin Oncol, 50:626-627, 2020
19. Gatellier L, Matsuda T, Sabapathy K, Dai M, Dewi LKM, Huong TT, Kardinah K, Thuan TV, Park JB, He J, Nansalmaa E, Luvsandorj B, Hwang WYK, Sengar M, Pramesh CS, Suzuki T. An Asian Body to Tackle Cancers in Asia - The Asian National Cancer Centers Alliance. Asian Pac J Cancer Prev, 21:1207-1212, 2020
20. Dewi LKM, Gatellier L, Sabapathy K, Pramesh CS, Dai M, Huong TT, Gultekin M, Nansalmaa E, Htwe KK, Yusuf A, Tahmasebi M, Pradhananga KK, Park JB, Hanapiah SM, Sangrajran S, Baral RP, Jayusman AM, Iwata S, Kwek JW, Sengar M, Chinnaswamy G, He J, Tian G, Huyen PT, Thuan TV, Luvsanjodorj B, Myint YY, Chun JY, Han JS, Hwang WYK, Sari NK, Matsuda T. An Asian Perspective of the Management of COVID-19: the Asian National Cancer Centers Alliance Led Regional Comparison. Asian Pac J Cancer Care, 5:27-42, 2020
Book
1. Siesling S, Wesselmann S, Mensah J, Brucker S, Colo F, Terrier F, Peeters MV, Honkoop A, Matsuda T. Examples of national programs on quality management. In: Verhoeven D, Kaufman C, Mansel R, Siesling S (ed), Breast cancer: Global quality care, USA, Oxford University Press, 2020